ImaRx Therapeutics, Inc.Tucson, AZ, United States (NASDAQ (CM): IMRX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

ImaRx Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 07 Dec 06 Dec 05
Revenue 8.4 1.3 0.6
Cost of Goods Sold 3.5 0.2 0.0
Gross Profit 4.8 1.1 --
Gross Profit Margin 57.9% 84.6% 0.0%
SG&A Expense 12.3 16.8 31.9
Depreciation & Amortization 1.2 1.0 0.2
Operating Income (8.7) (15.7) (31.3)
Operating Margin -- -- --
Nonoperating Income 0.8 16.5 4.0
Nonoperating Expenses 0.9 1.5 0.6
Income Before Taxes (8.8) (0.7) (27.9)
Income Taxes -- 0.0 0.0
Net Income After Taxes (8.8) (0.7) (27.9)

Continuing Operations (8.8) (0.7) (27.9)
Discontinued Operations -- 0.0 0.0
Total Operations (8.8) (0.7) (27.9)
Total Net Income (8.8) (0.7) (27.9)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (3.16) -- --
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online